Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Published on by Nano Technology

Dr. Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Dean, Internal Quality Assurance Cell (IQAC) | Mahayogi Gorakhnath University | India 

Dr. Raghu Ram Achar is an accomplished researcher with a strong publication-driven profile in biochemistry, biomedical sciences, and interdisciplinary life science research. His scholarly output comprises 114 research documents indexed in major databases, reflecting consistent contributions through original research articles, high-quality reviews, book chapters, books, and patents. According to Google Scholar, his work has received 1,342 citations, with an h-index of 19 and an i10-index of 36, demonstrating both sustained productivity and significant academic impact. His research spans enzymology, nanobiotechnology, tissue engineering, cancer biology, mitochondrial research, wound healing, bioinformatics, and computational drug discovery, with publications appearing in high-impact, peer-reviewed international journals. He has actively contributed to funded research projects, interdisciplinary R&D initiatives, innovation-driven studies, and translational research outcomes. His profile is further strengthened by research supervision, peer-review services for reputed journals, editorial and conference roles, and recognized scholarly contributions that collectively position him as a credible and impactful contributor to contemporary biomedical and life sciences research.

Citation Metrics (Google Scholar)

2000

1500

1000

500

0

Citations
1342

Documents
114

h-index
19

i10index
36

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Web Of Science  View Loop Profile  View Scilit Profile  View ScholarGPS

Featured Publications

Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Prof. Zhifeng You | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Professor | Shenzhen University of Advanced Technology | China

Prof. Zhifeng You is an emerging researcher in tissue engineering and regenerative biomaterials, with a strong focus on neural repair, nerve injury regeneration, and diabetic wound healing. His work integrates biomaterials, bioinks, and physical cues to advance translational strategies in regenerative medicine. He has published 27 peer-reviewed research articles, including high-impact reviews in leading materials and biomedical journals, contributing significantly to biomaterials-based neural and tissue repair research. His research output has received 1,129 Google Scholar citations, with an h-index of 15 and an i10-index of 18, reflecting consistent scholarly impact, innovation, and recognition within the global biomedical engineering and regenerative medicine research community.

Citation Metrics (Google Scholar)

1200

1000

800

600

400

200

0

Citations
1129

Documents
27

h-index
15

i10index
18

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Researcher Profile

Featured Publications

Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Prof. Dr. Young-Yul Kim | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Department Of Orthopedics | Catholic University of Korea | South Korea

Prof. Dr. Young-Yul Kim is a highly cited researcher in orthopedic spine surgery and regenerative biomaterials, with 2,505 Google Scholar citations across 111 scholarly documents, reflecting a strong h-index of 24 and i10-index of 52. His research integrates clinical spine science with advanced biomaterials, focusing on intervertebral disc degeneration, spinal disorders, biodegradable magnesium alloys, polymer-based and 3D/4D-printed scaffolds, and bone and cartilage regeneration. He has authored influential journal articles, high-impact reviews, and translational studies published in leading international journals, with several works serving as key references in disc biology, autophagy, necroptosis, and scaffold-based tissue engineering. His contributions extend to funded multidisciplinary research projects, innovation-driven R&D, and patented concepts in biodegradable implants and regenerative platforms. Prof. Dr. Young-Yul Kim has received multiple research awards and recognitions, actively contributes as a reviewer and editorial participant for international journals, and plays a significant role in shaping scientific discourse through conference leadership and invited scholarly activities, demonstrating sustained global research impact and innovation leadership.

Citation Metrics (Google Scholar)

3000

2500

2000

1500

1000

500

0

Citations
2505

Documents
111

h-index
24

i10index
52

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Researcher Profile

Featured Publications

Arthroscopic fixation technique for comminuted, displaced greater tuberosity fracture
– Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2010 | Citations: 126

Fang Wang | Nanomaterials for Medicine | Research Excellence Award

Published on by Nano Technology

Assoc. Prof. Dr. Fang Wang | Nanomaterials for Medicine | Research Excellence Award

China University of Petroleum | China

Assoc. Prof. Dr. Fang Wang is a highly cited researcher with significant contributions to nanotechnology and nanomedicine, reflected by 2,363 Scopus citations across 138 scholarly documents and an h-index of 27. Her research focuses on the design of multifunctional nanoplatforms for precision cancer therapy, integrating DNA nanotechnology, inorganic heterojunctions, and bioresponsive systems. She has made notable advances in targeted drug delivery, photothermal, photodynamic, chemodynamic, and synergistic chemo-therapeutic strategies using programmable nanocomplexes. Her work emphasizes structure–function relationships, catalytic enhancement, and light–matter interactions to achieve high therapeutic efficacy with minimal off-target effects. Assoc. Prof. Dr. Fang Wang’s research outcomes have been published in high-impact international journals, contributing to translational nanomedicine and advanced therapeutic design. She has actively contributed to interdisciplinary R&D, innovation-driven nanomaterial development, peer-review activities, and editorial and conference-related scholarly services, earning recognition for advancing next-generation smart nanotherapeutics.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2363

Documents
138

h-index
27

Citations

Documents

h-index

View Scopus Profile

Featured Publications


Manganese-doped CeO2 nanoparticles with phosphatase-like activity for dual-mode detection of aluminum ions
– Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025 | Citations: 2

Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Dr. Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Post-Doctorate | Shenzhen University | India

Dr. Shabnam Anjum is a postdoctoral researcher at Shenzhen University with a strong research footprint in biomaterials, nanofibrous scaffolds, extracellular vesicles, and regenerative medicine. Her work focuses extensively on the design, fabrication, and optimization of nanofibers, nanoparticles, microspheres, and hydrogels for tissue regeneration, particularly targeting bone, tendon, and ligament repair. She has contributed significantly to the advancement of electrospinning-based nanofibrous scaffolds, developing bioinspired core–shell systems, multifunctional drug-delivery constructs, and biomimetic matrices capable of modulating osteogenic and osteoclastic activity. Her publications in high-impact journals, including ACS Nano, Materials Today Bio, Frontiers in Bioengineering and Biotechnology, International Journal of Biological Macromolecules, and International Journal of Molecular Sciences, highlight her expertise in biomaterials, stem cell–derived extracellular vesicles, nanostructured drug-delivery systems, and regenerative therapeutics. She has authored influential review articles and innovative research papers demonstrating optimized electrospinning strategies, bioactive scaffold architectures, and decellularized matrix-based regenerative platforms. Her published findings collectively record 250 Scopus citations, 9 documents, and an h-index of 7. Dr. Shabnam Anjum’s emerging research pipeline includes cutting-edge studies on extracellular vesicle engineering, spatiotemporal therapeutic delivery, and osteoporotic bone regeneration. Her technical strengths span electrospinning, nanoparticle synthesis, advanced material characterization, microCT analysis, western blotting, qPCR, flow cytometry, and comprehensive biological evaluations. She has presented her research at prestigious scientific events such as the Chinese Biomaterials Conference and has actively engaged in global scientific webinars covering cancer research, stem cell biology, and precision medicine. She has also contributed to the scientific community through participation in specialized training programs on nanomaterials, animal experimentation, and polymer processing. Her research has been recognized through notable scholarships and academic distinctions, reflecting her dedication to innovative biomaterial development and regenerative therapy. Dr. Shabnam Anjum’s contributions continue to support advancements in nanotechnology-enabled regenerative medicine, positioning her as a promising researcher in the fields of tissue engineering, biomaterials design, and therapeutic nanotechnology.

Profiles: Scopus | Google Scholar | ResearchGate | Sci Profiles | Scilit | Loop

Featured Publications

1. Anjum, S., Rahman, F., Pandey, P., Arya, D. K., Alam, M., Rajinikanth, P. S., & Ao, Q. (2022). Electrospun biomimetic nanofibrous scaffolds: A promising prospect for bone tissue engineering and regenerative medicine. International Journal of Molecular Sciences, 23(16), 9206. https://doi.org/10.3390/ijms23169206

2. Kanaujiya, S., Arya, D. K., Pandey, P., Singh, S., Pandey, G., Anjum, S., … Rajinikanth, P. S. (2024). Resveratrol-ampicillin dual-drug loaded polyvinylpyrrolidone/polyvinyl alcohol biomimic electrospun nanofiber enriched with collagen for efficient burn wound repair. International Journal of Nanomedicine, 19, 5397–5418. https://doi.org/10.2147/IJN.S464046

3. Anjum, S., Wang, Y., Xin, Y., Li, X., Li, T., Zhang, H., Quan, L., Li, Y., Arya, D. K., … Ao, Q. (2024). Bioinspired core-shell nanofiber drug-delivery system modulates osteogenic and osteoclast activity for bone tissue regeneration. Materials Today Bio, 26, 101088. https://doi.org/10.1016/j.mtbio.2024.101088

4. Anjum, S., Li, T., Saeed, M., & Ao, Q. (2024). Exploring polysaccharide and protein-enriched decellularized matrix scaffolds for tendon and ligament repair: A review. International Journal of Biological Macromolecules, 254, 127891. https://doi.org/10.1016/j.ijbiomac.2023.127891

5. Arya, D. K., Deshpande, H., Kumar, A., Chidambaram, K., Pandey, P., Anjum, S., … Pandey, G. (2024). HER-2 receptor and αvβ3 integrin dual-ligand surface-functionalized liposome for metastatic breast cancer therapy. Pharmaceutics, 16(9), 1128. https://doi.org/10.3390/pharmaceutics16091128

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Published on by Nano Technology

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Efthymia Iliana Matthaiou, Albany Medical College, United States

Efthymia Iliana Matthaiou, PhD, is an Assistant Professor at Albany Medical College, NY, specializing in fungal infections and immunology. With a solid background in nanotechnology, immuno-oncology, and drug development, she leads cutting-edge translational research, developing novel therapies and diagnostics. Her expertise spans lung transplantation, cystic fibrosis, and autoimmune diseases. Dr. Matthaiou has a strong commitment to mentoring students, postdocs, and collaborators, and has been a key figure in advancing the study of fungal pathogens, including Aspergillus species. She holds several prestigious fellowships and grants, and has contributed significantly to scientific publications, particularly in the fields of immunology, transplantation, and nanomedicine.

Professional Profile:

Google Scholar

Orcid

Suitability for the “Best Researcher” Award: Efthymia Iliana Matthaiou, PhD

Summary of Suitability:

Dr. Efthymia Iliana Matthaiou is an exceptional candidate for the “Best Researcher” award due to her extensive and pioneering contributions in the fields of microbiology, immunology, and fungal infections. With a PhD from the University of Pennsylvania and Democritus University of Thrace, Dr. Matthaiou has advanced research into the molecular mechanisms of diseases such as cystic fibrosis and invasive fungal infections, focusing on immunomodulatory therapies and bioanalytical strategies.

🎓Education:

Dr. Matthaiou completed her postdoctoral training at Stanford University in 2020, focusing on lung immunology and transplantation. She earned her PhD from the University of Pennsylvania and Democritus University of Thrace in 2017, where her research centered on nanotechnology, immuno-oncology, and drug development. She graduated with the highest honors from Democritus University of Thrace with a BSc in 2011, marking the beginning of her promising scientific career.

🏢Experience:

Dr. Matthaiou is currently an Assistant Professor at Albany Medical College, where she leads a research laboratory focused on fungal infections and lung transplantation. Before this, she was a Lead Senior Scientist at Stanford University, leading several research initiatives on lung microenvironment, cystic fibrosis, and Aspergillus-related diseases. Her work includes developing immunomodulatory nanotherapies and studying host-pathogen interactions. She has also served as a postdoctoral researcher at Stanford, focusing on invasive aspergillosis in pediatric lung transplant patients and mentoring new hires and trainees.

🏅Awards and Honors:

Dr. Matthaiou has received several prestigious awards and fellowships, including the 2024 NCCAT-GUP3 Cryo-EM grant, for which she serves as Principal Investigator. She was also a Fellow of the 2022 Women’s Leadership Innovation Lab and received the 2019 Stanford MCHRI Postdoctoral Award, funding her research on innate immunity defects in cystic fibrosis and Aspergillus infections. These accolades highlight her leadership and contributions to the fields of immunology, transplantation, and infectious diseases.

🔬Research Focus:

Dr. Matthaiou’s research focuses on the intersection of fungal infections, immunology, and nanomedicine. Her work investigates the immune mechanisms that contribute to Aspergillus-related diseases, especially in the context of lung transplantation and cystic fibrosis. She is also exploring novel therapeutic approaches, such as nanoparticle-mediated drug delivery, to treat invasive aspergillosis. In addition, her research delves into macrophage dysregulation and its role in promoting fungal invasion, with the aim of developing immunomodulatory treatments to mitigate infection and improve patient outcomes.

Publication Top Notes:

  • Title: Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
    • Cited by: 89
  • Title: Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
    • Cited by: 78
  • Title: Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis
    • Cited by: 40
  • Title: Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
    • Cited by: 36
  • Title: The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial
    • Cited by: 17

 

 

 

 

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Published on by Nano Technology

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Dr. Stavros Melemenidis , Stanford University School of Medicine , United States

Stavros Melemenidis, DPhil, is a distinguished figure in the field of Radiation Oncology, currently serving as Director of Pre-clinical Radiotherapy and Research Scientist at Stanford University’s Department of Radiation Oncology in Stanford, CA, USA. He completed his DPhil in Radiation Biology at the University of Oxford, where his research focused on molecular targeted imaging methods for lung metastasis and angiogenesis detection. Dr. Melemenidis holds a diverse educational background including degrees from UCLA and the University of Liverpool. His expertise spans preclinical radiotherapy, ultra-high dose-rate irradiation experiments, and the development of advanced imaging probes and animal models for cancer research. Dr. Melemenidis is recognized for his contributions to radiation therapy and imaging sciences, employing innovative techniques to advance cancer treatment and research.

Professional Profile:

Scopus

🎓Education:

Stavros Melemenidis, DPhil, has pursued an extensive educational journey encompassing a diverse array of disciplines. He earned his DPhil in Radiation Biology from the University of Oxford, UK, focusing on the development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis. His academic credentials also include a Cert. in Medical Physics from UCLA, USA, an M.Sc. in Radiation Biology from the University of Oxford, UK, and an M.Sc. in Radiometrics; Instrumentation and Modelling from the University of Liverpool, UK. Dr. Melemenidis began his academic path with a B.Sc. in Physics: Medical Applications from the University of Liverpool and an A.Eng. in PC Systems and Peripheral Equipment from IIEK Neapoleos, Technical College, Greece. This diverse educational background has equipped him with expertise spanning radiation biology, medical physics, instrumentation, and modelling, contributing significantly to his research and leadership roles in the field of Radiation Oncology at Stanford University.

🏢Work Experience:

Stavros Melemenidis, DPhil, holds key positions in the field of Radiation Oncology at Stanford University in Stanford, CA, USA. Since January 2023, he has served as the Director of Pre-clinical Radiotherapy within the Department of Radiation Oncology, overseeing advanced research initiatives. Prior to this role, Dr. Melemenidis has been integral to the Division of Radiation Therapy as a Research Scientist since February 2020, contributing to innovative studies in radiation oncology. His earlier career includes impactful roles as a Postdoctoral Fellow at Stanford University from February 2016 to June 2020, where he focused on developing in vivo mouse tumor models and integrating imaging techniques with radiotherapy and immunotherapy. Previously, he was a Postdoctoral Fellow at the University of Oxford’s Department of Radiation Oncology from January 2015 to September 2015, conducting research on novel imaging probes for metastasis and angiogenesis detection. These experiences underscore Dr. Melemenidis’s dedication to advancing preclinical and clinical applications in radiation oncology through pioneering research and leadership.

Publication Top Notes:

  • Human enteroids as a tool to study conventional and ultra-high dose rate radiation
    • Authors: Klett, K.C., Martin-Villa, B.C., Villarreal, V.S., Loo Jr, B.W., Heilshorn, S.C.
    • Citations: 1
  • Real-time optical oximetry during FLASH radiotherapy using a phosphorescent nanoprobe
    • Authors: Ha, B., Liang, K., Liu, C., Loo, B.W., Pratx, G.
    • Citations: 4
  • Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension
    • Authors: Taylor, S., Isobe, S., Cao, A., Snyder, M.P., Rabinovitch, M.
    • Citations: 10
  • Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies
    • Authors: Jorge, P.G., Melemenidis, S., Grilj, V., Loo, B.W., Bailat, C.
    • Citations: 9